Improving viral vector safety for gene therapies
Drug Discovery World
AUGUST 21, 2024
Dr Andrea O’Hara, Senior Product Manager at Azenta Life Sciences asks why integration site analysis (ISA) is critical for the safety and efficacy of viral vectors for gene therapy. With these therapies, genes can be delivered into cells to replace defective alleles or produce new functional proteins to treat or cure disease.
59 
Let's personalize your content